cancer chemotherapy affects the function of the ovaries in pre-menopause, specifically its ability to produce estrogen and progesterone. The ovaries secrete these hormones within a cyclic manner reacting to trigger hormones manufactured by the pituitary gland. In the later section a ladies reproductive life, during her late 40s or early 50s, the ovaries no more produce these hormones and she is thus entering menopause. This action, where the ovaries turn off their sex hormone production, takes a few months to some year or so to happen. The gradual loss of estrogen and progesterone is frequently together with menopausal symptoms just like cessation of menstrual periods, hot flashes and vaginal dryness. Undergoing chemotherapy may accelerate menopause.
This basically ensures that during the very same time a woman is handling a breast cancers diagnosis, she must handle the changes and possible undesirable effects of the menopause. The same holds true for woman on hormone replacement therapy who must abruptly stop her hormone treatment a result of the diagnosis of breast cancers.
The association between breast cancer and endocrine status is complex and varies with all women. The common therapy for a recently diagnosed cancers of the breast patient would be to stop hormone replacement therapy. This is because it is often found from numerous researches that estrogen adds to the risk or breast cancers. Once, women with breast cancer were advised not to ever resume hormone replacement therapy or begin it. Fortunately, this practice has changed and nowadays, treatment is with each woman’s individual situation. Nevertheless, you will need to take into account the risks and important things about hormone replacement therapy when it comes to your disease.


